These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22737442)

  • 1. Survival of male breast cancer in fars, South of iran.
    Salehi A; Zeraati H; Mohammad K; Mahmoudi M; Talei AR; Ghaderi A; Imanieh MH; Fotouhi A
    Iran Red Crescent Med J; 2011 Feb; 13(2):99-105. PubMed ID: 22737442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Male breast cancer in the veterans affairs population: a comparative analysis.
    Nahleh ZA; Srikantiah R; Safa M; Jazieh AR; Muhleman A; Komrokji R
    Cancer; 2007 Apr; 109(8):1471-7. PubMed ID: 17342768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with recurrent breast cancer: does the primary axillary lymph node status predict more aggressive tumor progression?
    Rack B; Janni W; Gerber B; Strobl B; Schindlbeck C; Klanner E; Rammel G; Sommer H; Dimpfl T; Friese K
    Breast Cancer Res Treat; 2003 Nov; 82(2):83-92. PubMed ID: 14692652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.
    Diel IJ; Kaufmann M; Costa SD; Holle R; von Minckwitz G; Solomayer EF; Kaul S; Bastert G
    J Natl Cancer Inst; 1996 Nov; 88(22):1652-8. PubMed ID: 8931609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Male breast cancer; analysis of 58 cases in Shiraz, South of Iran.
    Tahmasebi S; Akrami M; Omidvari S; Salehi A; Talei A
    Breast Dis; 2010; 31(1):29-32. PubMed ID: 20644250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lobular invasive breast cancer prognostic factors: About 940 patients].
    Jauffret C; Houvenaeghel G; Classe JM; Garbay JR; Giard S; Charitansky H; Cohen M; Bélichard C; Faure C; Darai É; Hudry D; Azuar P; Villet R; Gimbergues P; Tunon de Lara C; Martino M; Coutant C; Dravet F; Chauvet MP; Chéreau Ewald E; Penault-Llorca F; Goncalves A; Lambaudie É
    Gynecol Obstet Fertil; 2015 Nov; 43(11):712-7. PubMed ID: 26482833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical features and risk factors for recurrence in mucinous breast cancer].
    Lei L; Chen ZZ; Zheng YB; Chen B; Wang X; Wang XJ
    Zhonghua Zhong Liu Za Zhi; 2017 Apr; 39(4):274-279. PubMed ID: 28550667
    [No Abstract]   [Full Text] [Related]  

  • 8. [Analysis of prognostic parameters in patients with breast cancer of size smaller than or equal to 2 cm].
    Xue C; Fu F; Wang C
    Zhonghua Bing Li Xue Za Zhi; 2015 Apr; 44(4):245-9. PubMed ID: 25975906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival outcomes of metaplastic breast cancer patients: results from a US population-based analysis.
    Nelson RA; Guye ML; Luu T; Lai LL
    Ann Surg Oncol; 2015 Jan; 22(1):24-31. PubMed ID: 25012264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
    Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
    Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional Lymph Node Involvement Is Associated With Poorer Survivorship in Patients With Chondrosarcoma: A SEER Analysis.
    Wan L; Tu C; Li S; Li Z
    Clin Orthop Relat Res; 2019 Nov; 477(11):2508-2518. PubMed ID: 31283732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer.
    Heimann R; Ferguson D; Powers C; Recant WM; Weichselbaum RR; Hellman S
    J Natl Cancer Inst; 1996 Dec; 88(23):1764-9. PubMed ID: 8944007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of extranodal extension in sentinel lymph node positive breast cancer.
    Yang X; Ma X; Yang W; Shui R
    Sci Rep; 2020 Sep; 10(1):14684. PubMed ID: 32895434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive role of tumor size in breast cancer with axillary lymph node involvement - can size of primary tumor be used to omit an unnecessary axillary lymph node dissection?
    Orang E; Marzony ET; Afsharfard A
    Asian Pac J Cancer Prev; 2013; 14(2):717-22. PubMed ID: 23621225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.
    Krag DN; Anderson SJ; Julian TB; Brown AM; Harlow SP; Costantino JP; Ashikaga T; Weaver DL; Mamounas EP; Jalovec LM; Frazier TG; Noyes RD; Robidoux A; Scarth HM; Wolmark N
    Lancet Oncol; 2010 Oct; 11(10):927-33. PubMed ID: 20863759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival analysis of 1148 women diagnosed with breast cancer in Southern Iran.
    Rezaianzadeh A; Peacock J; Reidpath D; Talei A; Hosseini SV; Mehrabani D
    BMC Cancer; 2009 Jun; 9():168. PubMed ID: 19497131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic factors of lymph node-negative metastasis gastric cancer].
    Sun D; Xu H; Huang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Prognostic Analysis of Male Breast Cancer (MBC) Compared with Post-Menopausal Female Breast Cancer (FBC).
    Yu XF; Yang HJ; Yu Y; Zou DH; Miao LL
    PLoS One; 2015; 10(8):e0136670. PubMed ID: 26313461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of factors influencing the axillary lymph node metastasis and breast cancer-specific survival in patients with T1 breast cancer].
    Jiao DC; Qiao JH; Zhu JJ; Wang LN; Ma YZ; Lu ZD; Liu ZZ
    Zhonghua Yi Xue Za Zhi; 2018 Oct; 98(40):3258-3262. PubMed ID: 30392292
    [No Abstract]   [Full Text] [Related]  

  • 20. Incidence and survival outcomes of early male breast cancer: a population-based comparison with early female breast cancer.
    Wang Y; Chen K; Yang Y; Tan L; Chen L; Zhu L; Su F; Liu X; Li S
    Ann Transl Med; 2019 Oct; 7(20):536. PubMed ID: 31807518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.